OTCQX:MRVFF - Post by User
Post by
paljoeyon Nov 09, 2014 12:09pm
573 Views
Post# 23111239
P 2 partner in Europe
P 2 partner in EuropePennsaid 2% has been licensed to Paladin Labs Inc. for Canada, South Africa, Israel and Central and South America and to NovaMedica LLC for Russia and some of the Community of Independent States. The product is not currently approved for sale or marketing in any of these countries.
Which is why Nuvo recently announced phase 3 trials in Europe.
Except that P2 is described for sports injuries which is somewhat different than osteoarritus of the knee prescribed in the US.
Who will they seek as their JV partner in Europe.
Endo seems obvious.
Or if P2 will be marketed in Europe as a over-the-counter drug, done so directly by NUvo.
Interesting options.